甲状腺癌患者血清促甲状腺激素水平的临床研究

doi:10.3969/j.issn.1674-490X.2015.01.012

医学研究与教育 ›› 2015, Vol. 32 ›› Issue (1): 51-54.DOI: 10.3969/j.issn.1674-490X.2015.01.012

甲状腺癌患者血清促甲状腺激素水平的临床研究

陈娜¹，靳小石²，矫政洧³

1. 河北大学临床学院，河北保定 071000；2. 河北大学附属医院普通外科，河北保定 071000；3. 河北大学附属医院门诊部，河北保定 071000

出版日期:2015-02-25 发布日期:2015-02-25
通讯作者: 靳小石（1973—），男，河北保定人，副主任医师，博士，硕士生导师，主要从事胃肠方面的临床研究。E-mail: doctorjinxiaoshi@126.com
作者简介:陈娜（1986—），女，河北衡水人，在读硕士，主要从事胃肠方面的临床研究。E-mail: 1015899462@qq.com

Clinical study on the serum levels of thyroid stimulating hormone of patients with thyroid cancer

CHEN Na¹, JIN Xiaoshi², JIAO Zhengwei³

1. College of Clinical Medicine, Heibei University, Baoding 071000, China; 2. Department of General Surgery, Affiliated Hospital of Hebei University, Baoding 071000, China; 3. Department of Outpatient, Affiliated Hospital of Hebei University, Baoding 071000, China

Online:2015-02-25 Published:2015-02-25

摘要/Abstract

摘要： 目的研究术前血清促甲状腺激素（TSH）水平与甲状腺癌之间的相关性。方法回顾性分析 200 例甲状腺疾病患者的性别、年龄、TSH水平、术后病理报告等临床资料。结果分化型甲状腺癌患者术前 TSH水平明显高于结节性甲状腺肿患者；分化型甲状腺癌患者中，年龄大于60岁患者的TSH水平显著升高。结论术前TSH水平可作为判断分化型甲状腺癌的一个辅助诊断指标。

关键词: 促甲状腺激素, 结节性甲状腺肿, 分化型甲状腺癌

Abstract: Objective To study the correlation between serum levels of thyroid stimulating hormone(TSH) and thyroid cancer. Methods A retrospective analysis of 200 case patients with thyroid disease were examined including sex, age, serum levels of thyroid stimulating hormone, pathological reports and other clinical date. Results The preoperative TSH level of patients with differentiated thyroid cancer were obviously higher than the patients with nodular goiter; the level of TSH in patients older than 60 with differentiated thyroid cancer increased significiently. Conclusion Preoperative TSH level can be used as an auxiliary diagnosis index of differentiated thyroid cancer.

Key words: thyroid stimulating hormone, nodular goiter, thyroid differentiated cancer

中图分类号:

R581

陈娜，靳小石，矫政洧. 甲状腺癌患者血清促甲状腺激素水平的临床研究[J]. 医学研究与教育, 2015, 32(1): 51-54.

CHEN Na, JIN Xiaoshi, JIAO Zhengwei. Clinical study on the serum levels of thyroid stimulating hormone of patients with thyroid cancer[J]. Medical Reserch and Education, 2015, 32(1): 51-54.

参考文献

[1] DAVIES L, WELCH H G. Increasing incidence of thyroid cancer in the United States, 1973-2002[J]. JAMA, 2006, 295(18): 2164-2167.
[2] CHEN A Y, JEMAL A, WARD E M, et al. Increasing incidence of diferentiated thyroid cancer in the United States, 1998-2005[J]. Cancer, 2009, 115(16): 3801-3807.
[3] BOELAERT K, HORACEK J, HOLDER R L, et al. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration[J]. J Clin Endocrinol Metab, 2006, 91(11): 4295-4301.
[4] KIM S S, LEE B J, LEE J C, et al. Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extra thyroidal extension in Korean patients: a single-center experience[J]. Endocrine, 2011, 39(3): 259-265.
[5] GERSCHPACHER M, GOBL C, ANDERWALD C, et al. Thyrotropin serum concentrations in patients with papillary thyroid microcancers[J]. Thyroid, 2010, 20(4): 389-392.
[6] FIORE E, RAGO T, PROVENZALE M A, et al. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role[J]. Endocr Relat Cancer, 2009, 16(4): 1251-1260.
[7] 史良凤, 关海霞, 李玉姝, 等. 术前血清促甲状腺激素水平与甲状腺结节良恶性关系的研究[J]. 中华内分泌代谢杂志, 2010, 26(3): 213-214.
[8] 李建周, 金勇君, 刘欣, 等. 血清促甲状腺素水平与甲状腺癌发病的相关性[J]. 中华肿瘤杂志, 2011, 12(33): 921-924.
[9] 朱霞瑾. 血清促甲状腺激素水平与甲状腺癌的相关性[J]. 中国现代医生, 2012, 50(31): 11-13.
[10] POLYZOS S A, KITA M, EFSTATHIADOU Z, et al. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules[J]. J Cancer Res Clin Oncol, 2008, 134(9): 953-960.
[11] HEGEDUS L, BONNEMA S J, BENNEDBAEK F N. Management of simplenodular goiter: current status and future perspectives[J]. Endoer Rev, 2003, 24( 11): 102-132.
[12] 于炳旗, 张刚, 王晓春, 等. 甲状腺 75 例临床治疗分析[J]. 河北职工医学院学报, 2008, 25(4): 17-18.
[13] CHO M A, LEE M K, NAM K H, et al. Expression and role of estrogen receptor α and β in medullary thyroid carcinoma: different roles in cancer growth and apoptosis[J]. J Endocrinol, 2007, (195): 255-263.
[14] KUMAR A, KLINGE C M, GOLDSTEIN R E. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta[J]. Int J Oncol, 2010, 36(5): 1067-1080.
[15] RAPARIA K, MIN S K, MODY D R, et al. Clinical outcomes for“suspicious”category in thyroid fine-needle aspiration biopsy: Patient's sex and nodule size are possible predictors of malignancy[J]. Arch Pathol Lab Med, 2009, 133(17): 787-790.
[16] 王有菊, 史虹莉. 甲状腺激素和年龄相关性的研究[J]. 中国临床保健杂志, 2008, 2(11): 51-53.
[17] 于晓会, 单忠艳. 甲状腺结节的病因与流行病学趋势[J]. 中国预防医学杂志, 2013, 14(4): 194-204.

甲状腺癌患者血清促甲状腺激素水平的临床研究

Clinical study on the serum levels of thyroid stimulating hormone of patients with thyroid cancer

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

本文评价

[1]	朱鹏里，李妍. 1 例疑似胺碘酮引起的甲状腺功能亢进症的分析与思考[J]. 医学研究与教育, 2014, 31(5): 110-112.
[2]	贾雄杰,宋艳茹. 急腹症诱发甲亢危象3例分析[J]. 医学研究与教育, 2009, 26(5): 35-.
[3]	贾雄杰,宋艳茹. 创伤诱发甲亢危象5例分析[J]. 医学研究与教育, 2009, 26(2): 44-45.